CSL689
CSL689_2001
Phase 3 small_molecule terminated
Quick answer
CSL689 for Hemophilia A With Inhibitors is a Phase 3 program (small_molecule) at CSL Behring GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CSL Behring GmbH
- Indication
- Hemophilia A With Inhibitors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated